Clinical Trials Logo

Ebola Virus Survivor clinical trials

View clinical trials related to Ebola Virus Survivor.

Filter by:
  • None
  • Page 1

NCT ID: NCT02739477 Terminated - Clinical trials for Ebola Virus Survivor

Tolerance and Activity Evaluation of High Doses of Favipiravir Against Ebola Virus in the Semen

FORCE
Start date: April 2016
Phase: Phase 2
Study type: Interventional

This study aims to evaluate favipiravir high dose tolerance in male survivor of Ebola Virus Disease (EVD) with Ebola Virus (EBOV) RNA in semen. This is a dose escalation study with 3 cohorts of 6 patients, each dose level including 2 sentinel patients.